Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,217.20
(
2.86%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
94.68
(
-6.45%
)
Bitcoin
71,395.63
(
-0.82%
)
News Focus
News Focus
Post# of 5029306
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

OTC BB King

Send PM Follow Ignore
Followers 644
Posts 57202
Boards Moderated 0
Alias Born 11/23/2004

OTC BB King

Re: Braden32601 post# 483190

Friday, 12/30/2005 12:15:02 PM

Friday, December 30, 2005 12:15:02 PM

Post# of 5029306
RGEN - could be a substantial lump sum payment for the patent or annual royalties based on sales of the product. The drug is projected to have a $1B market each year. The going rate for royalited is anywhere from 4-6% sales. The royalty payment could be in the range of $50-100M a year IMO. RGEN's current market cap is ONLY about $120M right now!

"Refuse to Lose"


This post only represents my opinion. Please buy and sell at your own risk only after proper DD. God Bless!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today